TLX Competitors & Alternatives
Compare Telix Pharmaceuticals Limited with similar stocks in the same industry
Biotechnology
TLX
Main Stock$9.89
Tradestie Score
46
Market Cap
$3.40B
Revenue Growth
0.5%
Analyst Upside
+112.4%
Top Competitors
229 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
AAPG
Ascentage Pharma Group International American Depository Shares
|
$17.43
|
$3.68B | - | 45 | Compare |
|
MIRM
Mirum Pharmaceuticals, Inc. Common Stock
|
$105.95
|
$3.67B | - | 59 | Compare |
|
ADMA
ADMA Biologics, Inc.
|
$8.46
|
$3.59B | 12.8 | 48 | Compare |
|
ACAD
Acadia Pharmaceuticals Inc.
|
$25.87
|
$3.58B | 11.9 | 58 | Compare |
|
LGND
Ligand Pharmaceuticals Inc.
|
$287.54
|
$3.49B | 37.6 | 57 | Compare |
|
QURE
uniQure N.V.
|
$43.63
|
$3.39B | - | 52 | Compare |
|
SRRK
Scholar Rock Holding Corporation Common Stock
|
$47.30
|
$3.33B | - | 52 | Compare |
|
NAMS
NewAmsterdam Pharma Company N.V. Ordinary Shares
|
$27.79
|
$3.31B | - | 50 | Compare |
|
SLNO
Soleno Therapeutics, Inc. Common Stock
|
$53.01
|
$3.20B | 27.5 | 49 | Compare |
|
MLYS
Mineralys Therapeutics, Inc. Common Stock
|
$25.52
|
$3.09B | - | 52 | Compare |
More TLX Analysis
Data updated: Aug 03, 2026 | Industry: Biotechnology (SIC 2834)
229 stocks in this industry